ISSN : ISSN No. 2172-0479
Translational Biomedicine journal stands out for its excellent contribution in dissemination of cutting-edge research in the field of Translational Biomedicine. The journal covers wide range of topics in this discipline and creates a platform for the authors to contribute towards the advancement in translational medicine, molecular medicine, translational genomics, clinical genetics, Translational research & clinical intervention, Translational stroke, Translational Neuroscience, Translational Oncology, Cardiovascular science, Stem cell Translational Medicine etc.
Since its inception in the year 2010, it has published large number of research articles, reviews, and case reports. The journal has become institution of knowledge for doctors, researchers, medical students. Translational Biomedicine is running in its 11th volume, with approximately 4 issues per year. It has achieved the confidence and interest of numerous researchers across the globe, to publish and propagate their exiting scientific findings through our journal.
A statistical representation of global users for Translational Biomedicine (Source: Google Analytics)
A statistical representation of global users for Translational Biomedicine (Source: Google Analytics)
iMedPub was established in the year 2005 and since then has been actively publishing peer-reviewed articles in biomedical and clinical science; material science; mathematics and engineering topics. iMedPub follows standard editorial and production policies with Internationally acclaimed publication practices.
Due to wide variation in the journal portfolio, the publisher site is accessed by various communities of diverse scientific disciplines from reputed research organizations, academic institution and Government bodies. More than 6,781,894 users have accessed the publisher website with more than 17,950,990 page views. These stats reveal that the journal is also immensely popular among scientific societies and organizations. Consequently, the editorial board profiles, authors and their affiliations are also gaining higher visibility.
The number of web sessions, the publisher received was 8,509,611 at the rate of 2.11 new sessions. This implied that new users and visitors are flocking to the publisher bases. A number of users are also revisiting the publisher pages indicating their continued interest in the journal. The fast and efficient publishing standard set by iMedPub was found to be very impressive by the reader base and is being well appreciated; as evident from the web metrics. The metric displayed belong only to our journals and if the associated links are also taken into consideration the number would be significantly much higher.
Translational Biomedicine received 1026 citations as per Google Scholar report